8 Days Left to Apply: Join 1,000 Investors and 2,000 High-Quality Projects at China’s Premier Medical Innovation Showcase

Mar 23, 2025 08:00 CST Updated 08:00

In recent years, China has deeply implemented its innovation-driven development strategy. With the in-depth application of cutting-edge technologies such as artificial intelligence in the healthcare sector, the upgrading of traditional industries, and the rapid growth of emerging industries, innovative forces in China’s healthcare field are poised for significant advancement. As the first ranking list in China focused on innovative medical companies that are not publicly listed, the “Top 100 Future Healthcare Companies” selection has been committed to discovering and promoting innovative transformations in China’s healthcare industry since its inception in 2015. All rankings and award results will be announced on-site during the Top 100 Future Healthcare and Pharmaceutical Companies Exhibition.Past editions of the Future Healthcare 100 Expo have attracted over 1,000 investment institutions and 2,000 high-quality projects, creating a high-specification, high-quality platform for industry exchange and exhibition in China’s healthcare sector.

With only 8 days remaining until the announcement of the 2025 Future Healthcare Top 100, we cordially invite all stakeholders in the healthcare industry to register and showcase the vibrant vitality of China’s healthcare sector.

8-Day Countdown: Quick Update on Application Progress

The 2025 Future Healthcare Top 100 selection includes the Future Healthcare Top 100 Ranking and the Future Healthcare Top 100 Innovation Awards. Since the call for entries was launched, innovative enterprises, investment institutions, innovative products, and industrial parks have actively participated. To date, the 2025 Future Healthcare Top 100 selection has received over 800 applications, demonstrating strong enthusiasm and innovative vitality across all sectors of the healthcare industry.

More than 500 companies have applied for the Future Healthcare Top 100 Rankings, with 100 new entrants emerging.

More than 500 companies have applied for the 2025 Future Healthcare Top 100 Rankings. Among them, applications for the Innovative Medical Devices and Intelligent Manufacturing list accounted for 30.65%, with major applicants covering cardiovascular devices, high-end ophthalmic equipment, surgical robots, imaging equipment, orthopedics, and in vitro diagnostics. The Innovative Pharmaceuticals and Biological Products list accounted for 22.04%, primarily covering innovative oncology drugs, cell and gene therapy drugs, and nucleic acid drugs. The Medical and Health Innovation Services list accounted for 36.56%, mainly covering health management, healthcare informatization, smart elderly care, and specialized clinics. The Medical and Health Industry Chain Services list accounted for 10.75%, primarily covering pharmaceutical and medical device CRO/CDMO, digital intelligence service platforms, and pharmaceutical marketing platforms.

From the perspective of applicant composition, 80 of the top 30 valued companies on each main list in 2024 have completed their applications, demonstrating active participation from industry leaders. Meanwhile, 100 new companies that had never previously applied have emerged, injecting fresh vitality into the rankings and showcasing the robust development and innovative dynamism of the healthcare sector.

【Main List Application Express】

直通车.png

https://vb100.mike-x.com/BYQrY

Over 60 investment institutions submitted applications, with 30+ firms specializing in innovative sectors participating

For institutional awards, investment firms demonstrated strong enthusiasm, with over 60 institutions submitting applications. Notably, among the top 30 institutions ranked by cumulative investment count in 2024, 25 actively participated in the application process. Nomination interest among investment firms in the innovation track continued to rise, attracting applications from more than 30 institutions. These firms have shown keen interest in frontier technological fields such as biomedical large language models, gene editing technology, biomedical imaging, synthetic biology, and biomanufacturing, steadily increasing their investments and providing robust support for the rapid growth of the innovation sector.

In addition to institutional award selections, the 2025 VBEF Institutional High-Quality Project Investment Promotion Conference and Innovative Asset Poster Exhibition will also empower outstanding investment institutions by showcasing their investment achievements and facilitating in-depth transactions of high-quality assets. Through a multi-dimensional synergy of "dynamic roadshows + static exhibitions," these two events not only provide institutions with scenarios for in-depth analysis that transcend industrial cycles but also promote the formation of a complete ecological closed loop of "value discovery – value validation – value realization."

【Investment Institution Application Channel】

机构类.png

https://vb100.mike-x.com/PSMZj

(Promotion and capital application consultation: Ms. Li from VCBeat, 18428384021)

Product Registrations Surpass 200 Companies, with Over 80 First-in-Class Products

The Product Innovation Awards focus on hot sectors such as biotechnology, digital technology, and intelligent medical devices. To date, more than 200 innovative products have been submitted for the awards, including over 80 first-of-their-kind products. This surge in innovation aligns with data from the 2024 Annual Drug Evaluation Report, which shows that 66 innovative medical devices were approved nationwide in 2024. The number of approved innovative medical devices has remained at a high level for two consecutive years, covering key technological areas such as surgical robots, cardiopulmonary support systems, and artificial intelligence. Meanwhile, 48 Class 1 innovative drugs were approved, spanning nearly 20 therapeutic areas including oncology, neurological disorders, endocrine diseases, and anti-infectives, fully demonstrating the comprehensive enhancement of China’s innovation capabilities in pharmaceutical and medical device products.

This year, the Organizing Committee has also comprehensively upgraded the Product Launch Conference and the Product Showcase. From the numerous outstanding products selected for the “2025 Future Healthcare Top 100 Selection · Product Award,” it has carefully curated the most representative high-quality innovative assets in healthcare and pharmaceuticals (products/solutions) for centralized launch and exhibition. Projects awarded the Product Award will have the opportunity to gain direct access to the 2025 VBEF Top 100 Award-Winning Products Launch Conference and Innovative Product Showcase, thereby transforming product innovation into quantifiable and tradable asset value.

[Product Registration Channel]

产品类.png

https://vb100.mike-x.com/gW56w

(For inquiries regarding the press conference and joint exhibition, please contact Mr. Tang at VCBeat: 15683660525)

Over 40 industrial parks have submitted applications, covering future healthcare hub cities such as Beijing, Shanghai, Shenzhen, Suzhou, and Guangzhou.

More than 40 industrial parks independently applied for park-related awards, with over 46% of them choosing to apply for the “Annual Healthcare Leader Park” award. The applicant parks are located in cities such as Beijing, Shanghai, Shenzhen, Suzhou, and Guangzhou—regions that serve not only as core clusters for the healthcare industry but also as pioneering demonstration zones for innovative resources and industrial ecosystems. In terms of sectoral distribution, the applying parks cover multiple cutting-edge fields, including biopharmaceuticals, medical devices, gene technology, digital health, and synthetic biology, reflecting the diversified layout and robust growth momentum of the healthcare industry.

Only 8 days left until the submission deadline! We look forward to more innovative forces joining us in writing a new chapter for the industry!

Enrollment Benefits

1. Brand Exposure:Award-winning organizations will be announced alongside the 2025 Future Healthcare Top 100 rankings across VCBeat’s official website and the VB100 media matrix, significantly enhancing corporate brand visibility and influence, while providing ongoing matchmaking services with industry players, investors, and industrial parks.

2. Award Ceremony:Award-winning enterprises will be invited to attend the awards ceremony at the 9th VBEF Future Healthcare & Pharmaceutical Top 100 Exhibition, where they can engage in face-to-face exchanges with industry peers and spark collaborative opportunities.

3. Direct access to the award ceremony for the Top 100 products and the exhibition of innovative product collections:Product Award: Selected products have the opportunity to be showcased as representative high-quality innovative assets in the medical and pharmaceutical sector, participating in product launch events and featured exhibitions, while engaging in in-depth discussions on business opportunities with over 2,000 supply chain companies and distribution agents in attendance.

4. VCBeat Top 100 Growth Report:Award-winning organizations will have the opportunity to be featured as exemplary case studies in the “2025 Top 100 Future Healthcare Companies Growth Report,” showcasing their corporate growth stories and exploring industry development trends.

5. VCBeat Closed-Door Seminar:Outstanding award-winning organizations will have the opportunity to be invited to closed-door seminars hosted by VCBeat, where they can engage with government representatives and senior investors in discussions on corporate implementation policies and untapped commercialization opportunities.

Participation Returns

1. Docking with Industrial Parks/Investment Institutions: VBEF provides enterprises with follow-up matchmaking services, connecting them to 50 listed supporting investment institutions and 30 listed supporting industrial parks, while addressing their financing and operational landing needs to empower business growth.

2. Opportunity to be interviewed by VCBeat:When planning VCBeat’s innovative enterprise interview series, priority is given to selecting companies that have applied for the “Top 100 Future Healthcare Companies” list, and the full interview transcripts are published on the VCBeat official website to enhance the brands’ influence.

3. Obtain tickets to the Top 100 Exhibitions:Participating organizations that submit their application materials will receive two all-access passes to the “9th VBEF Future Healthcare & Pharma Top 100 Exhibition,” enabling in-depth exchanges with government officials, industry peers, potential partners, and other professionals at the event.

4. Opportunity to receive priority invitations to VBEF’s year-round events:Participating organizations will be included in the VBEF Expert Database, receive regular email updates on VBEF’s year-round activities, and may be invited to serve as speakers if they meet the event requirements.

Application Method

Each applicant entity may directly complete the application by filling in the required information online through the corresponding application channel.

[Institutional Application Channel]

机构类.png